(Total Views: 242)
Posted On: 11/09/2022 1:35:50 PM
Post# of 35

$RPRX News Article - Arrowhead Sells Royalty Interest in Olpasiran to Royalty Pharma for $250 Million and Future Milestones https://marketwirenews.com/news-releases/arro...14767.html


My Twitter: WhyteStocks